Related Experiment Video
Updated: Jun 6, 2025

Analyzing DNA-Protein Interactions with Streptavidin-Based Biolayer Interferometry
Published on: January 17, 2025
A multifaceted approach to understanding protein-buffer interactions in biopharmaceuticals
Blaž Lebar1, Maria Orehova2, Boštjan Japelj3
1University of Ljubljana, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Aškerčeva 7, SI-1000 Ljubljana, Slovenia; Novartis Pharmaceutical Manufacturing LLC, Kolodvorska 27, SI-1234 Menges, Slovenia.
Identifying weak protein-excipient interactions is key for biopharmaceutical stability. This study used advanced NMR and simulations to reveal rituximab interactions, improving drug formulation design.
Area of Science:
- Biopharmaceutical Formulation
- Protein Chemistry
- Analytical Chemistry
Background:
- Excipient selection is critical for biopharmaceutical drug product stability.
- Protein-excipient interactions are proposed stabilization mechanisms but are difficult to identify.
- Weak and transient nature of these interactions poses a significant challenge.
Purpose of the Study:
- To present a comprehensive approach for identifying protein-excipient interactions.
- To investigate interactions between rituximab and various excipients.
- To enhance understanding of stabilization mechanisms for rational formulation design.
Main Methods:
- Utilized 1H T2 CPMG (Carr-Purcel-Meiboom-Gill) filter experiments.
- Employed chemometric analyses of 2D NMR fingerprints.
- Performed molecular dynamics simulations to identify potential interaction sites.
Main Results:
- Identified specific interactions between rituximab and certain buffers/amino acids.
- Revealed interactions between selected excipients and antibody fragments using NMR.
- Discovered potential interacting hotspots via molecular dynamics simulations, even without NMR assignment.
Conclusions:
- An orthogonal methods approach is vital for uncovering critical protein-excipient interactions.
- The study advances the understanding of excipient stabilization mechanisms.
- Findings support rational formulation design in biopharmaceutical development.
More Related Videos
19:16The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis
Published on: March 17, 2010
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Related Concept Videos
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Protein Buffers in Blood Plasma and Cells
Certain amino acids can exist in a zwitterion state at a...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Drug Distribution: Plasma Protein Binding